U.S. market Closed. Opens in 4 hours 30 minutes

EVAX | Evaxion Biotech A/S Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue73.00KN/AN/AN/AN/AN/A
Cost of Revenue112.00571.32K343.45K105.72K80.98K73.93K
Gross Profit72.89K-571.32K-343.45K-105.72K-80.98K-73.93K
Operating Expenses22.25M25.26M25.83M16.57M10.86M5.63M
Selling, General & Admin10.35M8.21M6.25M5.67M2.63M1.88M
Research & Development11.92M17.06M19.58M10.90M8.22M3.73M
Other Operating ExpensesN/AN/AN/AN/A16.00K15.00K
Operating Income-22.20M-25.26M-25.83M-16.57M-10.86M-5.63M
Other Expenses / Income-718.00K1.32M1.12M-7.00K-1.16M-636.93K
Before Tax Income-22.91M-23.94M-24.71M-16.57M-12.02M-6.27M
Income Tax Expenses-791.22K-772.00K-178.00K-1.56M-825.00K-735.00K
Net Income-22.12M-23.17M-24.53M-15.02M-11.20M-5.54M
Interest Expenses897.00K1.51M915.00K223.00K1.22M698.00K
Basic Shares Outstanding2.73M2.36M1.95M1.62M1.62M1.92M
Diluted Shares Outstanding2.73M2.36M1.95M1.62M1.62M1.92M
EBITDA-21.40M-22.58M-24.17M-16.46M-11.90M-6.18M
EBITDA Margin-29,319.18%0.00%0.00%0.00%0.00%0.00%
EBIT-22.02M-22.43M-23.80M-16.35M-10.80M-5.57M
EBIT Margin-30,163.31%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙